The abstract is read at the publisher; the summary is JClub's.
In osteoclast-lineage cells from postmenopausal osteoporosis patients and ovariectomized mice, mitochondrial citrate carrier CIC (SLC25A1) is elevated and linked to osteoclast markers.
- Why it matters: Osteoclast formation depends on coordinated mitochondrial energy use and glutathione-based redox control, but how these programs are mechanistically connected remains unclear.
- What they did: CIC was tracked during osteoclastogenesis and inhibited with CTPI-2, followed by transcriptomic/metabolomic profiling and tests of the glutathione synthesis axis via GCL inhibition.
- The result: CIC inhibition suppressed osteoclastogenesis, disrupted mitochondrial metabolism, increased GSH synthesis and reduced reactive oxygen species, and osteoclast-targeted CIC silencing in OVX mice mitigated bone loss.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.